Introduction: Caudal blocks are a common pediatric regional anesthesia technique used to alleviate intra- and postoperative pain following circumcision. The addition of the alpha-2 agonist clonidine has been shown to increase the duration of the block. Another method for prolonging the effect of the block is using a high-volume, low-concentration (HVLC) local anesthetic in the caudal solution. The primary aim of this study was to compare the duration of caudal blockade using HVLC with and without clonidine. The effect of epidural clonidine on postoperative emergence agitation (EA) was assessed as a secondary outcome. Methodology: This was a prospective, randomized, and observer-blinded study. The participants comprised 129 children, aged 0-3 years, classified as American Society of Anesthesiologists Physical Status Class 1-2, who underwent circumcision and received a caudal injection comprising 1.5 mL/kg of 0.15% ropivacaine and 5 µg/mL of epinephrine after anesthesia induction. The no-clonidine (NC) group received no additional caudal additive, whereas the clonidine (C) group received 1 µg/mL of clonidine. The research team instructed the patients' parents to administer oral acetaminophen when they detected a pain level corresponding to a visual analog scale score ≥4 on the Wong-Baker FACES Pain Rating Scale or when they felt that their child was uncomfortable. EA occurrence was measured by post-anesthesia care unit nurses using the Pediatric Anesthesia Emergence Delirium (PAED) scale.
Results: No significant differences were observed between the two groups regarding demographics, anesthesia, surgery, or discharge time. The median time to the first postoperative acetaminophen dose was 335 min for the NC group and 381 min for the C group (P = 0.901). The NC group had a mean PAED score of 6.5 compared with 6.4 in the C group (P = 0.894).
Conclusion: In children who underwent circumcision, adding clonidine to the HVLC caudal injection of ropivacaine did not prolong the time to the first acetaminophen dose or the occurrence of EA, suggesting no benefit in using clonidine in this surgical population.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699843 | PMC |
http://dx.doi.org/10.7759/cureus.75151 | DOI Listing |
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common pediatric psychiatric disorders and is frequently diagnosed and treated by pediatricians. Stimulant medications are the first-line treatment for ADHD but may not be a good fit for many patients due to side effects, inadequate treatment response, or family preference. Non-stimulant ADHD medications provide a useful alternative for patients that cannot tolerate stimulants, have an incomplete treatment response to stimulants, are at risk for stimulant diversion, or whose family prefers to avoid stimulants.
View Article and Find Full Text PDFCureus
December 2024
Anesthesiology and Perioperative Medicine, Medical University of South Carolina, Charleston, USA.
J Anaesthesiol Clin Pharmacol
August 2024
Department of Anesthesiology, RNT Medical College, Udaipur, Rajasthan, India.
Background And Aims: Bloodless surgical field during functional endoscopic sinus surgery (FESS) is an essential part, and research continues to find simple and effective regime for it. This study was aimed to compare the efficacy of oral clonidine versus oral metoprolol as premedicants regarding surgical field condition and controlled hypotension in patients undergoing FESS.
Material And Methods: Sixty-eight patients of American Society of Anesthesiologists (ASA) physical status (PS) I and II aged 18-60 years, of both genders, scheduled for FESS under general anesthesia were randomly allocated in two groups.
J Control Release
January 2025
Department of Dermatology, Hunan Engineering Research Center of Skin Health and Disease, Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; Furong Laboratory (Precision Medicine), Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha 410008, China. Electronic address:
The immunosuppressive tumor microenvironment (TME) plays a crucial role in the progression and treatment resistance of melanoma. Modulating the TME is thus a key strategy for enhancing therapeutic outcomes. Recent studies have identified clonidine (CLD), an α2-adrenergic receptor agonist, as a promising agent that enhances T lymphocyte infiltration and reduces myeloid-derived suppressor cells within the TME, thereby promoting antitumor immune responses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!